Trichomoniasis immunity and the involvement of the purinergic signaling
- PMID: 27793265
- PMCID: PMC6138788
- DOI: 10.1016/j.bj.2016.06.007
Trichomoniasis immunity and the involvement of the purinergic signaling
Abstract
Innate and adaptive immunity play a significant role in trichomoniasis, the most common non-viral sexually transmitted disease worldwide. In the urogenital tract, innate immunity is accomplished by a defense physical barrier constituted by epithelial cells, mucus, and acidic pH. During infection, immune cells, antimicrobial peptides, cytokines, chemokines, and adaptive immunity evolve in the reproductive tract, and a proinflammatory response is generated to eliminate the invading extracellular pathogen Trichomonas vaginalis. However, the parasite has developed complex evolutionary mechanisms to evade the host immune response through cysteine proteases, phenotypic variation, and molecular mimicry. The purinergic system constitutes a signaling cellular net where nucleotides and nucleosides, enzymes, purinoceptors and transporters are involved in almost all cells and tissues signaling pathways, especially in central and autonomic nervous systems, endocrine, respiratory, cardiac, reproductive, and immune systems, during physiological as well as pathological processes. The involvement of the purinergic system in T. vaginalis biology and infection has been demonstrated and this review highlights the participation of this signaling pathway in the parasite immune evasion strategies.
Keywords: Adaptive immune response; Evasion mechanisms; Innate immune response; Purinergic signaling; Trichomoniasis.
Copyright © 2016 Chang Gung University. Published by Elsevier B.V. All rights reserved.
Comment on
-
Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.Glycoconj J. 2009 Jan;26(1):3-17. doi: 10.1007/s10719-008-9157-1. Epub 2008 Jul 6. Glycoconj J. 2009. PMID: 18604640 Free PMC article.
Similar articles
-
The Role of Purinergic Signaling in Trichomonas vaginalis Infection.Curr Top Med Chem. 2021;21(3):181-192. doi: 10.2174/1568026620999200904122212. Curr Top Med Chem. 2021. PMID: 32888270 Review.
-
Immunity in urogenital protozoa.Parasite Immunol. 2014 Sep;36(9):400-8. doi: 10.1111/pim.12114. Parasite Immunol. 2014. PMID: 25201404 Review.
-
Neutrophil interactions with the sexually transmitted parasite Trichomonas vaginalis: implications for immunity and pathogenesis.Open Biol. 2020 Sep;10(9):200192. doi: 10.1098/rsob.200192. Epub 2020 Sep 2. Open Biol. 2020. PMID: 32873151 Free PMC article. Review.
-
Adenosine reduces reactive oxygen species and interleukin-8 production by Trichomonas vaginalis-stimulated neutrophils.Purinergic Signal. 2017 Dec;13(4):569-577. doi: 10.1007/s11302-017-9584-1. Epub 2017 Sep 6. Purinergic Signal. 2017. PMID: 28879644 Free PMC article.
-
Impact of T. vaginalis infection on innate immune responses and reproductive outcome.J Reprod Immunol. 2009 Dec;83(1-2):185-9. doi: 10.1016/j.jri.2009.08.007. Epub 2009 Oct 21. J Reprod Immunol. 2009. PMID: 19850356 Free PMC article. Review.
Cited by
-
High Presence of NETotic Cells and Neutrophil Extracellular Traps in Vaginal Discharges of Women with Vaginitis: An Exploratory Study.Cells. 2022 Oct 11;11(20):3185. doi: 10.3390/cells11203185. Cells. 2022. PMID: 36291053 Free PMC article.
-
Immunopathology of Recurrent Vulvovaginal Infections: New Aspects and Research Directions.Front Immunol. 2019 Aug 28;10:2034. doi: 10.3389/fimmu.2019.02034. eCollection 2019. Front Immunol. 2019. PMID: 31555269 Free PMC article. Review.
-
Trichomoniasis.Infect Dis Clin North Am. 2023 Jun;37(2):245-265. doi: 10.1016/j.idc.2023.02.001. Epub 2023 Mar 31. Infect Dis Clin North Am. 2023. PMID: 37005163 Free PMC article. Review.
-
Trichomoniasis and Other Sexually Transmitted Parasitic Diseases in Women.Clin Obstet Gynecol. 2025 Jun 1;68(2):194-205. doi: 10.1097/GRF.0000000000000945. Epub 2025 Apr 14. Clin Obstet Gynecol. 2025. PMID: 40226933 Free PMC article. Review.
-
Introduction of protein vaccine candidate based on AP65, AP33, and α-actinin proteins against Trichomonas vaginalis parasite: an immunoinformatics design.Parasit Vectors. 2024 Mar 31;17(1):165. doi: 10.1186/s13071-024-06248-y. Parasit Vectors. 2024. PMID: 38556882 Free PMC article.
References
-
- WHO . Global incidence and prevalence of selected curable sexually transmitted infections: 2008. World Health Organization, Department of Reproductive Health and Research; 2012. pp. 207–209.
-
- Lehker M.W., Alderete J.F. Biology of trichomonosis. Curr Opin Infect Dis. 2000;13:37–45. - PubMed
-
- Muzny C.A., Schwebke J.R. The clinical spectrum of Trichomonas vaginalis infection and challenges to management. Sex Transm Infect. 2013;89:423–425. - PubMed
-
- Gardner W.A., Jr., Culberson D.E., Bennett B.D. Trichomonas vaginalis in the prostate gland. Archives Pathology Laboratory Med. 1986;110:430–432. - PubMed
-
- Poole D.N., McClelland R.S. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect. 2013;89:418–422. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources